Emmanuelle Trombe and Anthony Paronneau advised the French biopharmaceutical company DBV Technologies on the launch of an exclusive worldwide collaboration with Nestlé Health Science to develop and market an innovative standardized test that detects infants’ allergies to the proteins in cows’ milk.